160 related articles for article (PubMed ID: 1756224)
1. Non-polarized cell surface expression of HLA-A,B,C and HLA-DR antigens in Graves' thyroid follicle cells.
Mölne J; Nilsson M; Jansson S; Hansson G; Ericson LE
Autoimmunity; 1991; 10(3):189-99. PubMed ID: 1756224
[TBL] [Abstract][Full Text] [Related]
2. Adherence of RFD-1 positive dendritic cells to the basal surface of thyroid follicular cells in Graves' disease.
Mölne J; Jansson S; Ericson LE; Nilsson M
Autoimmunity; 1994; 17(1):59-71. PubMed ID: 8025214
[TBL] [Abstract][Full Text] [Related]
3. Induction of microsomal antigen and comparison with histologic localization of HLA-DR in Graves' thyroid tissue.
Roman SH; Goldsmith NK; Leiderman IZ; Davies TF
Autoimmunity; 1989; 2(3):253-63. PubMed ID: 2491609
[TBL] [Abstract][Full Text] [Related]
4. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide and 3-aminobenzamide inhibit recombinant human interferon-gamma-induced HLA-DR antigen expression, but not HLA-A, B, C antigen expression, on cultured human thyroid cells.
Hiromatsu Y; Sato M; Yamada K; Nonaka K
Clin Endocrinol (Oxf); 1992 Jan; 36(1):91-5. PubMed ID: 1532770
[TBL] [Abstract][Full Text] [Related]
6. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease].
Lacka K; Kordel M; Gembicki M
Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):179-81. PubMed ID: 2682567
[TBL] [Abstract][Full Text] [Related]
7. Expression of HLA-DR antigens by thyroid cells: the effect of Graves' IgG.
Bodolay E; Szegedi G; Suranyi P; Juhasz F; Stenszky V; Balazs C; Farid NR
Immunol Lett; 1987 May; 15(1):77-81. PubMed ID: 3111991
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.
Hanafusa T; Pujol-Borrell R; Chiovato L; Russell RC; Doniach D; Bottazzo GF
Lancet; 1983 Nov; 2(8359):1111-5. PubMed ID: 6138646
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune and non-autoimmune thyroid diseases have different patterns of cellular HLA class II expression.
Zantut-Wittmann DE; Boechat LH; Pinto GA; da Silva Trevisan MA; Vassallo J
Sao Paulo Med J; 1999 Jul; 117(4):161-4. PubMed ID: 10559851
[TBL] [Abstract][Full Text] [Related]
10. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations.
Inoue D; Sato K; Enomoto T; Sugawa H; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
Clin Endocrinol (Oxf); 1992 Jan; 36(1):75-82. PubMed ID: 1559302
[TBL] [Abstract][Full Text] [Related]
11. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
[TBL] [Abstract][Full Text] [Related]
12. Ectopic expression of HLA class II antigens on thyroid follicular cells: induction and transfer in vitro by autologous mononuclear leukocytes.
Khoury EL; Greenspan JS; Greenspan FS
J Clin Endocrinol Metab; 1988 Nov; 67(5):992-1004. PubMed ID: 2972740
[TBL] [Abstract][Full Text] [Related]
13. Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in Graves' disease.
Zantut-Wittmann DE; Tambascia MA; da Silva Trevisan MA; Pinto GA; Vassallo J
Thyroid; 2001 Jun; 11(6):575-80. PubMed ID: 11442005
[TBL] [Abstract][Full Text] [Related]
14. Effects of supernatants of peripheral blood mononuclear cells stimulated by thyroid microsomal antigen on thyrocyte HLA-dr expression in vitro.
Matsubayashi S; Sakatsume Y; Kasuga Y; Tamai H; Volpé R
Autoimmunity; 1990; 8(2):91-6. PubMed ID: 2129496
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells.
Faure GC; Bensoussan-Lejzerowicz D; Bene MC; Aubert V; Leclere J
Clin Immunol Immunopathol; 1997 Aug; 84(2):212-5. PubMed ID: 9245555
[TBL] [Abstract][Full Text] [Related]
16. Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production.
Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1988 Aug; 11(4):279-85. PubMed ID: 3262474
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR antigen expression on intrathyroidal lymphocytes and thyrocytes in Hashimoto's thyroiditis and Graves' disease: an immunohistological study.
Misaki T; Konishi J; Arai K; Iida Y; Kasagi K; Kuma K; Torizuka K
Endocrinol Jpn; 1987 Apr; 34(2):257-62. PubMed ID: 3113922
[TBL] [Abstract][Full Text] [Related]
18. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.
Grubeck-Loebenstein B; Londei M; Greenall C; Pirich K; Kassal H; Waldhäusl W; Feldmann M
J Clin Invest; 1988 May; 81(5):1608-14. PubMed ID: 3130398
[TBL] [Abstract][Full Text] [Related]
19. The in vitro regulation of human thyrocyte HLA-DR antigen expression.
Weetman AP; Volkman DJ; Burman KD; Gerrard TL; Fauci AS
J Clin Endocrinol Metab; 1985 Nov; 61(5):817-24. PubMed ID: 2995430
[TBL] [Abstract][Full Text] [Related]
20. Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease.
Ishikawa N; Eguchi K; Ueki Y; Nakashima M; Shimada H; Ito K; Nagataki S
Clin Exp Immunol; 1993 Nov; 94(2):363-70. PubMed ID: 7900942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
